Atlas FDA

HOUVA III Phototherapy System with DermaSense Technology comes on one skid within 10 cardboard boxes. A therapeutic prod

FDA device recall Z-1309-2008 · posted 2008-08-28 · Terminated

Recall details

Recalling firm
National Biological Corp
Reason for recall
Software allows operator to override "low line voltage" error warning and store light intensity value.
Action taken
National Biological sent an "Important safety reminders for your Houva DermaSense phototherapy device" letters, dated 2/11/08 to users. It states that the user should collect a "Profile" of the light energy and record it on a daily/weekly flow chart. The chart should be in plain view so each operator can clearly determine the units output. If an error message appears in the display panel, treatment should not be continued unless the phototherapy booth operator was able to identify and correct the cause of the error. Make sure both breakers are in the "ON" position before starting up the unit each morning and before giving treatment.
Root cause
Software design
Status
Terminated
Product code
FTC
Quantity affected
48 Units
Distribution
Worldwide distribution --- USA including states of: CA, DE, FL, GA, ID, IL, IN, MA, MI, MN, NC, NH, NY, OH, OR, PA, TX, VA, WA and WI, and country of Canada.
Date initiated
2008-02-19
Date posted
2008-08-28
Date terminated
2011-09-20
Location
Beachwood, OH

Monitor recalls programmatically

Recalls and clearances share one API, with change alerts when new recalls post.

Related 510(k) clearances

RecordFirmDate
HOUVA 3 PHOTOTHERAPY SYSTEM (K041212)National Biological Corp.2004-06-09